A Lyme disease vaccine could be available soon, Axios reports.
Earlier this month, Moderna announced two new development candidates for mRNA vaccines against Lyme disease.
Pfizer and Valneva also have a vaccine candidate — VLA15 — that’s already in late-stage clinical trials, but many of their clinical trial participants, including children as young as 5 years old, were discontinued due to violations of Good Clinical Practice in how trial sites were run by third-party operators.
However, Pfizer and Valneva say they can still apply for approval from the Food and Drug Association as early as 2025.
